5-Amino-1MQ 50mg (60 Capsules)

5-Amino-1MQ 50mg capsules (60 per bottle) are offered by Peptide Sciences for research into nicotinamide N-methyltransferase (NNMT) inhibition and cellular energy metabolism.

5-Amino-1MQ and NNMT Research

NNMT is an enzyme highly expressed in adipose tissue that consumes NAD+ precursors and the methyl donor SAM. 5-Amino-1-methylquinolinium is a small, membrane-permeable NNMT inhibitor. In mouse models of diet-induced obesity it reduced fat-cell size and increased intracellular NAD+ levels, making it a useful compound for studying the link between NNMT, NAD+ metabolism and adipocyte biology.

5-Amino-1MQ 50mg Specifications

Research Benefits of the Capsule Format

Pre-measured 50mg capsules make oral dosing in animal research straightforward and repeatable. Researchers studying NAD+ pathways may also compare results with our NAD+ vials.

Quality Control, COA and Shipping

Our release testing covers purity (HPLC), identity (MS) and appearance for every production lot. Orders include the lot-matched COA and leave our US warehouse in insulated, tamper-evident packaging to keep research material stable.

Related Research Compounds

Researchers working with 5-Amino-1MQ often compare results with these catalog compounds:

• Longevity, Performance & Obesity Research (60 Capsules)
• SLU-PP-332 (1000mcg x 30 Capsules = 30,000mcg)
• NAD+ 100mg
• Gut Inflammation (60 Capsules) (Stable BPC-157, KPV, PEA, Tributyrin)

Explore the full Peptide Capsules collection, browse the complete Peptide Sciences research peptide catalog, or review published literature on 5-Amino-1MQ in PubMed.

Research use only. This product is sold strictly for in-vitro laboratory research and development by qualified professionals. It is not for human or veterinary use, not a drug, food or cosmetic, and has not been evaluated by the FDA to diagnose, treat, cure or prevent any disease. Buyers must be 21+ and comply with all applicable laws.